Logo image of 703.DE

ALFEN N.V. (703.DE) Stock Fundamental Analysis

Europe - FRA:703 - NL0012817175 - Common Stock

10.025 EUR
-0.04 (-0.4%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, 703 scores 4 out of 10 in our fundamental rating. 703 was compared to 61 industry peers in the Electrical Equipment industry. 703 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 703 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 703 has reported negative net income.
In the past year 703 had a positive cash flow from operations.
703 had positive earnings in 4 of the past 5 years.
Each year in the past 5 years 703 had a positive operating cash flow.
703.DE Yearly Net Income VS EBIT VS OCF VS FCF703.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.09%, 703 is doing worse than 62.30% of the companies in the same industry.
703's Return On Equity of -11.40% is in line compared to the rest of the industry. 703 outperforms 40.98% of its industry peers.
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
703.DE Yearly ROA, ROE, ROIC703.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Gross Margin of 703 (34.60%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of 703 has declined.
The Profit Margin and Operating Margin are not available for 703 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
703.DE Yearly Profit, Operating, Gross Margins703.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

703 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 703 remains at a similar level compared to 1 year ago.
703 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 703 has been reduced compared to a year ago.
703.DE Yearly Shares Outstanding703.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
703.DE Yearly Total Debt VS Total Assets703.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.63 indicates that 703 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of 703 (2.63) is better than 70.49% of its industry peers.
The Debt to FCF ratio of 703 is 0.99, which is an excellent value as it means it would take 703, only 0.99 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.99, 703 belongs to the best of the industry, outperforming 91.80% of the companies in the same industry.
703 has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.26, 703 is in the better half of the industry, outperforming 67.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Altman-Z 2.63
ROIC/WACCN/A
WACC7.36%
703.DE Yearly LT Debt VS Equity VS FCF703.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

703 has a Current Ratio of 1.75. This is a normal value and indicates that 703 is financially healthy and should not expect problems in meeting its short term obligations.
703 has a better Current ratio (1.75) than 62.30% of its industry peers.
703 has a Quick Ratio of 1.09. This is a normal value and indicates that 703 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.09, 703 is in the better half of the industry, outperforming 65.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.09
703.DE Yearly Current Assets VS Current Liabilites703.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for 703 have decreased strongly by -287.72% in the last year.
703 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.84%.
The Revenue has been growing by 27.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%

3.2 Future

The Earnings Per Share is expected to grow by 39.04% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.90% on average over the next years.
EPS Next Y102.15%
EPS Next 2Y100%
EPS Next 3Y75.65%
EPS Next 5Y39.04%
Revenue Next Year-7.68%
Revenue Next 2Y-1.24%
Revenue Next 3Y1.55%
Revenue Next 5Y2.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
703.DE Yearly Revenue VS Estimates703.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
703.DE Yearly EPS VS Estimates703.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

703 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 31.40, which means the current valuation is very expensive for 703.
The rest of the industry has a similar Price/Forward Earnings ratio as 703.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, 703 is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 31.4
703.DE Price Earnings VS Forward Price Earnings703.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 703.
Based on the Price/Free Cash Flow ratio, 703 is valued cheaper than 95.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.39
EV/EBITDA 27.27
703.DE Per share data703.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

703's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 703's earnings are expected to grow with 75.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y75.65%

0

5. Dividend

5.1 Amount

No dividends for 703!.
Industry RankSector Rank
Dividend Yield N/A

ALFEN N.V.

FRA:703 (10/17/2025, 7:00:00 PM)

10.025

-0.04 (-0.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-04 2025-11-04
Inst Owners42.06%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap218.04M
Analysts41.25
Price Target10.83 (8.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.66%
PT rev (3m)-11.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-89.4%
EPS NY rev (3m)-99.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-9.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.4
P/S 0.48
P/FCF 4.39
P/OCF 3.36
P/B 1.44
P/tB 1.79
EV/EBITDA 27.27
EPS(TTM)-0.79
EYN/A
EPS(NY)0.32
Fwd EY3.19%
FCF(TTM)2.28
FCFY22.77%
OCF(TTM)2.99
OCFY29.81%
SpS20.85
BVpS6.96
TBVpS5.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.6%
FCFM 10.95%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Debt/EBITDA 4.36
Cap/Depr 56.5%
Cap/Sales 3.38%
Interest Coverage N/A
Cash Conversion 709.26%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.09
Altman-Z 2.63
F-Score5
WACC7.36%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
EPS Next Y102.15%
EPS Next 2Y100%
EPS Next 3Y75.65%
EPS Next 5Y39.04%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%
Revenue Next Year-7.68%
Revenue Next 2Y-1.24%
Revenue Next 3Y1.55%
Revenue Next 5Y2.9%
EBIT growth 1Y-211.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year691.73%
EBIT Next 3Y125.96%
EBIT Next 5Y65.41%
FCF growth 1Y164.76%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y242.64%
OCF growth 3Y74.32%
OCF growth 5Y31.69%